Article
cfDNA Sequencing: Technological Approaches and Bioinformatic Issues
21 Jun 2021
Abstract excerpt
In the era of precision medicine, it is crucial to identify molecular alterations that will guide the therapeutic management of patients. In this context, circulating tumoral DNA (ctDNA) released by the tumor in body fluids, like blood, and carrying its molecular characteristics is becoming a powerful biomarker for non-invasive detection and monitoring of cancer. Major recent technological advances, especially in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
